| GO ID | Ontology | GO Term | Term Definition |
Proteins |
GO:2001033 | BP | negative regulation of double-strand break repair via nonhomologous end joining | Any process that stops, prevents or reduces the frequency, rate or extent of double-strand break repair via nonhomologous end joining. |
HMGA2 |
GO:2001034 | BP | positive regulation of double-strand break repair via nonhomologous end joining | Any process that activates or increases the frequency, rate or extent of double-strand break repair via nonhomologous end joining. |
RIF1 |
GO:2001037 | BP | positive regulation of tongue muscle cell differentiation | Any process that activates or increases the frequency, rate or extent of tongue muscle cell differentiation. |
TBX1, CYP26B1 |
GO:2001038 | BP | regulation of cellular response to drug | Any process that modulates the frequency, rate or extent of cellular response to drug. |
HMGA2, NCOA1 |
GO:2001044 | BP | regulation of integrin-mediated signaling pathway | Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway. |
ITGB1BP1, TIMP1, PRKD1 |
GO:2001045 | BP | negative regulation of integrin-mediated signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of integrin-mediated signaling pathway. |
CTNNA1, PHACTR4 |
GO:2001046 | BP | positive regulation of integrin-mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of integrin-mediated signaling pathway. |
FLNA, EMP2 |
GO:2001054 | BP | negative regulation of mesenchymal cell apoptotic process | Any process that stops, prevents or reduces the frequency, rate or extent of mesenchymal cell apoptotic process. |
TBX1, GDF5, SOX9, HIF1A |
GO:2001056 | BP | positive regulation of cysteine-type endopeptidase activity | Any process that activates or increases the frequency, rate or extent of cysteine-type endopeptidase activity. |
PYCARD |
GO:2001076 | BP | positive regulation of metanephric ureteric bud development | Any process that activates or increases the frequency, rate or extent of metanephric ureteric bud development. |
WT1 |
GO:2001106 | BP | regulation of Rho guanyl-nucleotide exchange factor activity | Any process that modulates the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity. |
CCPG1 |
GO:2001108 | BP | positive regulation of Rho guanyl-nucleotide exchange factor activity | Any process that activates or increases the frequency, rate or extent of Rho guanyl-nucleotide exchange factor activity. |
EPHA4 |
GO:2001113 | BP | negative regulation of cellular response to hepatocyte growth factor stimulus | Any process that stops, prevents or reduces the frequency, rate or extent of cellular response to hepatocyte growth factor stimulus. |
ADAMTS12 |
GO:2001135 | BP | regulation of endocytic recycling | Any process that modulates the frequency, rate or extent of endocytic recycling. |
RAB11B, BVES, NDRG4 |
GO:2001137 | BP | positive regulation of endocytic recycling | Any process that activates or increases the frequency, rate or extent of endocytic recycling. |
ACTN2, SORL1 |
GO:2001140 | BP | positive regulation of phospholipid transport | Any process that activates or increases the frequency, rate or extent of phospholipid transport. |
TRIAP1, PRELID1 |
GO:2001141 | BP | regulation of RNA biosynthetic process | Any process that modulates the frequency, rate or extent of RNA biosynthetic process. |
MITF, NCOA3 |
GO:2001150 | BP | positive regulation of dipeptide transmembrane transport | Any process that activates or increases the frequency, rate or extent of dipeptide transmembrane transport. |
CA2 |
GO:2001153 | BP | positive regulation of renal water transport | Any process that activates or increases the frequency, rate or extent of renal water transport. |
INPP5K |
GO:2001170 | BP | negative regulation of ATP biosynthetic process | Any process that stops, prevents or reduces the frequency, rate or extent of ATP biosynthetic process. |
PID1, FLCN |
GO:2001171 | BP | positive regulation of ATP biosynthetic process | Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process. |
STAT3, VCP, PID1, PINK1, PPARGC1A |
GO:2001180 | BP | negative regulation of interleukin-10 secretion | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-10 secretion. |
TNFRSF21, LILRB1 |
GO:2001181 | BP | positive regulation of interleukin-10 secretion | Any process that activates or increases the frequency, rate or extent of interleukin-10 secretion. |
PYCARD |
GO:2001182 | BP | regulation of interleukin-12 secretion | Any process that modulates the frequency, rate or extent of interleukin-12 secretion. |
FOXP1 |
GO:2001183 | BP | negative regulation of interleukin-12 secretion | Any process that stops, prevents or reduces the frequency, rate or extent of interleukin-12 secretion. |
LILRB1 |
GO:2001184 | BP | positive regulation of interleukin-12 secretion | Any process that activates or increases the frequency, rate or extent of interleukin-12 secretion. |
MAPK14 |
GO:2001186 | BP | negative regulation of CD8-positive, alpha-beta T cell activation | Any process that stops, prevents or reduces the frequency, rate or extent of CD8-positive, alpha-beta T cell activation. |
HFE, LILRB1 |
GO:2001189 | BP | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | Any process that stops, prevents or reduces the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell. |
LGALS3, LILRB1 |
GO:2001190 | BP | positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | Any process that activates or increases the frequency, rate or extent of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell. |
HLA-DMB |
GO:2001193 | BP | positive regulation of gamma-delta T cell activation involved in immune response | Any process that activates or increases the frequency, rate or extent of gamma-delta T cell activation involved in immune response. |
LILRB1 |
GO:2001199 | BP | negative regulation of dendritic cell differentiation | Any process that stops, prevents or reduces the frequency, rate or extent of dendritic cell differentiation. |
HLA-G, TMEM176B, LILRB1, TMEM176A |
GO:2001200 | BP | positive regulation of dendritic cell differentiation | Any process that activates or increases the frequency, rate or extent of dendritic cell differentiation. |
HMGB1 |
GO:2001202 | BP | negative regulation of transforming growth factor-beta secretion | Any process that stops, prevents or reduces the frequency, rate or extent of transforming growth factor-beta secretion. |
FN1, LILRB1 |
GO:2001204 | BP | regulation of osteoclast development | Any process that modulates the frequency, rate or extent of osteoclast development. |
TYROBP |
GO:2001205 | BP | negative regulation of osteoclast development | Any process that stops, prevents or reduces the frequency, rate or extent of osteoclast development. |
FBN1, LILRB1 |
GO:2001206 | BP | positive regulation of osteoclast development | Any process that activates or increases the frequency, rate or extent of osteoclast development. |
TNFSF11 |
GO:2001212 | BP | regulation of vasculogenesis | Any process that modulates the frequency, rate or extent of vasculogenesis. |
EMP2, HEY1 |
GO:2001213 | BP | negative regulation of vasculogenesis | Any process that stops, prevents or reduces the frequency, rate or extent of vasculogenesis. |
XDH |
GO:2001214 | BP | positive regulation of vasculogenesis | Any process that activates or increases the frequency, rate or extent of vasculogenesis. |
ADM, RAP1A |
GO:2001222 | BP | regulation of neuron migration | Any process that modulates the frequency, rate or extent of neuron migration. |
PLXNB2, FLRT2, ULK4, ZSWIM6 |
GO:2001223 | BP | negative regulation of neuron migration | Any process that stops, prevents or reduces the frequency, rate or extent of neuron migration. |
GNRH1, COL3A1, STAT3, NRG1, ERBB4, ADGRG1 |
GO:2001224 | BP | positive regulation of neuron migration | Any process that activates or increases the frequency, rate or extent of neuron migration. |
SEMA3A, NSMF, KIF20B, SEMA6A |
GO:2001225 | BP | regulation of chloride transport | Any process that modulates the frequency, rate or extent of chloride transport. |
CA2 |
GO:2001229 | BP | negative regulation of response to gamma radiation | Any process that stops, prevents or reduces the frequency, rate or extent of response to gamma radiation. |
PRKDC |
GO:2001234 | BP | negative regulation of apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of apoptotic signaling pathway. |
BCL2, CTH, CTNNB1, NR4A2, PSEN1, IGBP1, BAX, MNT, MEIS3 |
GO:2001235 | BP | positive regulation of apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of apoptotic signaling pathway. |
INHBB, CTSH, TGFBR1, MAPK9, CTSC, CRADD, PRKCD, NFATC4, TPD52L1, TP53INP1, TRIM39 |
GO:2001236 | BP | regulation of extrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
TRAF1, DEPTOR |
GO:2001237 | BP | negative regulation of extrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
NRP1, CFLAR, SIAH2, NOL3, LMNA, IGF1, ITGAV, THBS1, GSTP1, AR, BMP4, SCG2, LGALS3, ITGA6, TGFBR1, HTT, YAP1, GCLC, GCLM, PSME3, RELA, ACVR1, RIPK1, CTTN, ZMYND11, RB1CC1, PHIP, TCF7L2, PAK7 |
GO:2001238 | BP | positive regulation of extrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
BCL10, AGT, G0S2, PDIA3, LTBR, AGTR2, TNFSF10, BID, CAV1, HYAL2, FADD, PAK2, RIPK1, GPER1, TNFRSF12A, CYLD, PYCARD |
GO:2001239 | BP | regulation of extrinsic apoptotic signaling pathway in absence of ligand | Any process that modulates the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
FGFR1 |
GO:2001240 | BP | negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
EYA2, SNAI2, EYA4, TNF, IL1A, IL1B, PF4, FYN, HSPA1A, HSPA1B, BCL2, AKT1, CTNNA1, MCL1, MAP2K5, MAPK7, RIPK1, UNC5B, STRADB |
GO:2001241 | BP | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand. |
DAPK3, INHBA, FAS, PPP2R1A, PPP2R1B, CTNNA1, TGFB2, PPP1CA, BAX |
GO:2001242 | BP | regulation of intrinsic apoptotic signaling pathway | Any process that modulates the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
CYLD, PYCARD |
GO:2001243 | BP | negative regulation of intrinsic apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
DDX3X, URI1, GCG, BCL2, MMP9, PPIF, VDAC2, PLAUR, MCL1, BCL2L2, NDUFA13, MAPK8IP1, NOC2L, IVNS1ABP |
GO:2001244 | BP | positive regulation of intrinsic apoptotic signaling pathway | Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway. |
BCL2L11, PRKRA, TP53, S100A8, S100A9, BCL2, BCAP31, BID, RACK1, CAV1, BAX, PMAIP1, SIAH1, FLCN, BAD, BCLAF1 |
GO:2001250 | BP | positive regulation of ammonia assimilation cycle | Any process that activates or increases the frequency, rate or extent of ammonia assimilation cycle. |
NR1H4 |
GO:2001256 | BP | regulation of store-operated calcium entry | Any process that modulates the frequency, rate or extent of store-operated calcium entry. |
STC2, SPINK1, HOMER1 |
GO:2001257 | BP | regulation of cation channel activity | Any process that modulates the frequency, rate or extent of cation channel activity. |
HOMER1, KCNIP2 |
GO:2001258 | BP | negative regulation of cation channel activity | Any process that stops, prevents or reduces the frequency, rate or extent of cation channel activity. |
MMP9, FGF12 |
GO:2001259 | BP | positive regulation of cation channel activity | Any process that activates or increases the frequency, rate or extent of cation channel activity. |
CTSS, ACTN2, ANK2, ANK3, KCNJ11 |
GO:2001268 | BP | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway | Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in apoptotic signaling pathway. |
MMP9, PLAUR |
GO:2001271 | BP | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis | Any process that stops, prevents or reduces the frequency, rate or extent of cysteine-type endopeptidase activity involved in execution phase of apoptosis. |
PAK2, RFFL |
GO:2001273 | BP | regulation of glucose import in response to insulin stimulus | Any process that modulates the frequency, rate or extent of glucose import in response to insulin stimulus. |
NGFR, REPIN1 |
GO:2001274 | BP | negative regulation of glucose import in response to insulin stimulus | Any process that stops, prevents or reduces the frequency, rate or extent of glucose import in response to insulin stimulus. |
PID1 |
GO:2001275 | BP | positive regulation of glucose import in response to insulin stimulus | Any process that activates or increases the frequency, rate or extent of glucose import in response to insulin stimulus. |
AGT, PIK3R1, AKT2, IRS1, RNASEL, PTPN11, C2CD5, NR1H4, RARRES2, OSBPL8 |
GO:2001287 | BP | negative regulation of caveolin-mediated endocytosis | Any process that stops, prevents or reduces the frequency, rate or extent of caveolin-mediated endocytosis. |
UNC119 |
GO:2001288 | BP | positive regulation of caveolin-mediated endocytosis | Any process that activates or increases the frequency, rate or extent of caveolin-mediated endocytosis. |
NEDD4L |
GO:2001295 | BP | malonyl-CoA biosynthetic process | The chemical reactions and pathways resulting in the formation of malonyl-CoA, the S-malonyl derivative of coenzyme A. |
ACACB |
GO:2001300 | BP | lipoxin metabolic process | The chemical reactions and pathways involving a lipoxin. A lipoxin is a non-classic eicosanoid and signalling molecule that has four conjugated double bonds and is derived from arachidonic acid. |
ALOX5, HPGD |
GO:2001303 | BP | lipoxin A4 biosynthetic process | The chemical reactions and pathways resulting in the formation of lipoxin A4. Lipoxin A4 is a C20 hydroxy fatty acid having (5S)-, (6R)- and (15S)-hydroxy groups as well as (7E)- (9E)-, (11Z)- and (13E)-double bonds. |
ALOX15 |
GO:2001311 | BP | lysobisphosphatidic acid metabolic process | The chemical reactions and pathways involving a lysobisphosphatidic acid. A lysobisphosphatidic acid is a lysophosphatidic acid having the unusual property of a phosphodiester moiety linked to positions sn-1 and sn1' of glycerol; and two additional fatty acids esterified to the glycerol head group. |
ACP6 |